Healthcare -
Biotechnology - NASDAQ - US
$ 5.25
8.25 %
$ 111 M
Market Cap
-0.96
P/E
ENTA - CAPITAL EXPENDITURES
Capital Expenditures ENTA - Enanta Pharmaceuticals, Inc.
-17.9 M
LAST VALUE
-190.62%
2 YEAR CAGR
-27.07%
5 YEAR CAGR
-33.11%
10 YEAR CAGR